AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
48.24
-2.02 (-4.02%)
Oct 1, 2026, 3:07 PM EDT - Market open
AnaptysBio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $70 → $60 | Buy | Reiterates | $70 → $60 | +24.38% | Sep 30, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $90 → $81 | Buy | Maintains | $90 → $81 | +67.91% | Sep 23, 2026 |
| Barclays | Barclays | Buy Maintains $75 | Buy | Maintains | $75 | +55.47% | Sep 23, 2026 |
| UBS | UBS | Buy Reiterates $76 | Buy | Reiterates | $76 | +57.55% | Sep 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $95 | Buy | Reiterates | $95 | +96.93% | Sep 22, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $93 | Buy | Maintains | $93 | +92.79% | Jul 21, 2026 |
| Wedbush | Wedbush | Buy Reiterates $60 → $75 | Buy | Reiterates | $60 → $75 | +55.47% | Mar 31, 2026 |